LobbyingStonington Global lobbying by quarter
Stonington Global's latest lobbying report covers Q3 2021, at $15K. Its first report covers Q4 2020; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.
Stonington Global
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2020
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2020 | $10K | 1 |
| Q1 2021 | $0 | 0 |
| Q2 2021 | $15K | 1 |
| Q3 2021 | $15K | 1 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $0 | 0 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$20K · 3 reports
- Medical research and clinical labs$20K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)3 reports
- Health & Human Services, Dept of (HHS)3 reports
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Significant Consulting | $40K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/10/18for Q4 2020 | Significant Consulting | $10K |
| 23/10/18for Q3 2021 | Significant Consulting | $15K |
| 23/10/18for Q2 2021 | Significant Consulting | $15K |